Cigna to Align Executive Compensation with Customer Satisfaction Metrics
In a significant shift towards enhancing customer experience, Cigna Corp., the health care giant, has announced a pivotal change in its executive compensation strategy. Starting this year, the company plans to tie a portion of its executives' pay to customer satisfaction scores. This innovative approach reflects a growing trend in the corporate world whereby businesses recognize the importance of customer feedback in driving success and profitability.
Continue reading
Cigna Takes Action to Ease Out-of-Pocket Drug Costs for U.S. Patients
The health insurance giant Cigna has announced a significant change in its policy aimed at alleviating the financial burdens on U.S. patients regarding out-of-pocket costs for medications. This new initiative is set to limit how much patients are required to pay out of their own pockets for necessary prescription drugs, reflecting a growing trend among insurers to tackle rising healthcare expenses.
Continue reading
FTC Takes Action Against CVS, Cigna, and UnitedHealth Over Allegations of Abuse in Pharmaceutical Middleman Role
In a significant move that could reshape the landscape of the pharmaceutical industry, the Federal Trade Commission (FTC) has launched an investigation into three prominent players—CVS Health, Cigna, and UnitedHealth Group. The agency accuses these companies of exploiting their positions as pharmacy benefit managers (PBMs) and engaging in practices that allegedly harm consumers and distort competition.
Continue reading
Trump's Controversial Comments Trigger Major Stock Declines for CVS, UnitedHealth, and Cigna
In a surprising turn of events, shares of major health insurance and pharmacy companies experienced significant declines following remarks made by former President Donald Trump. This unexpected downturn primarily impacted CVS Health Corp, UnitedHealth Group, and Cigna, raising concerns among investors and analysts alike about the potential implications for the healthcare sector.
Continue reading
New York State Unveils Strict Regulations for Pharmacy Benefit Managers
In a significant move aimed at curbing the influence of Pharmacy Benefit Managers (PBMs), New York State has introduced new regulations that are expected to reshape how these organizations operate. The legislation primarily targets well-known names in the industry such as CVS, Cigna, and UnitedHealth, enforcing greater transparency and accountability in their practices.
Continue reading
Cigna Officially Withdraws from Pursuing Merger with Humana
In a surprising turn of events, Cigna has confirmed that it will not be moving forward with its plans to merge with fellow insurer Humana. This decision signifies a significant shift in the competitive landscape of the health insurance industry, where consolidation has been a growing trend.
Continue reading
Cigna Surpasses Profit and Revenue Expectations Driven by Evernorth Growth
Cigna Corporation has reported impressive third-quarter results that significantly exceeded analyst expectations, underpinned by strong growth from its health services marketplace, Evernorth. This growth not only bolstered Cigna's overall financial performance but also solidified its position in the competitive healthcare sector.
Continue reading
Cigna and Humana Merger Prospects: The Election's Critical Role
As the countdown to the 2024 elections intensifies, analysts suggest that the impending political landscape may significantly influence the potential merger between Cigna Corporation and Humana Inc. According to industry experts, the deal's success could be heavily reliant on the outcome of federal elections, which might determine the regulatory environment for large healthcare mergers.
Continue reading
Cigna Revives Merger Talks with Humana After Previous Halt
In a surprising turn of events, Cigna Corp has begun to re-engage in merger discussions with Humana Inc., signaling a potential shake-up in the healthcare insurance sector. This renewed dialogue comes almost a year after talks between the two companies were abruptly terminated, primarily due to regulatory hurdles and market uncertainties that plagued the industry at that time.
Continue reading